Market Overview

UPDATE: Morgan Stanley Reiterates On LifePoint Hospitals Following 3Q14 Report


In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on LifePoint Hospitals (NASDAQ: LPNT), but removed the $76.00 price target.

In the report, Morgan Stanley noted, “Our updated 2015 EBITDA est. of $700M reflects improving utilization trends and reform. The quarter saw positive underlying reform metrics as LPNT saw greater SS self-pay declines vs. 2Q. Separately, volumes in the quarter improved with SS equivalent admissions up 4.5% Y/Y.”

LifePoint Hospitals closed on Friday at $70.73.

Latest Ratings for LPNT

Jul 2018MaintainsNeutralNeutral
Jul 2018MaintainsMarket PerformMarket Perform
Jul 2018DowngradesOutperformNeutral

View More Analyst Ratings for LPNT
View the Latest Analyst Ratings

Posted-In: Andrew Schenker Morgan StanleyAnalyst Color Price Target Analyst Ratings


Related Articles (LPNT)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Citigroup Names Dicks Sporting Goods, Foot Locker As Top Apparel And Footwear Picks

Welcome The Rise Of Helicopters